Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ulcerative Colitis Acute: later-stage trial registry
2 of 3 indexed Ulcerative Colitis Acute trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Ulcerative Colitis Acute: 3 US clinical trials tracked, 2 recruiting.
Ulcerative Colitis Acute is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Berinstein, Jeffrey, running 2 of these trials.
Enrollment posture brief
Registry condition ulcerative-colitis-acute
OPEN 2 | RECR 67% | LATE 2 | EARLY 1 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Ulcerative Colitis Acute lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ulcerative Colitis Acute on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ulcerative Colitis Acute is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis
Berinstein, Jeffrey
NCT05867329
Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis
Berinstein, Jeffrey
NCT07258771
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Palatin Technologies
NCT05466890
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Ulcerative Colitis Acute records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ulcerative Colitis Acute trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ulcerative Colitis Acute page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Ulcerative Colitis Acute trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Berinstein, Jeffrey sponsors the most Ulcerative Colitis Acute trials on record, review their full trial history before evaluating a specific study. See Berinstein, Jeffrey's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ulcerative Colitis Acute condition card totals 3 registered trials; most-linked intervention Intravenous Methylprednisolone; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.